It only arrived in the UK a little over 20 months ago, but since its release, Mounjaro has transformed the market for GLP-1 medicines, with more than half of the 1.5 million people taking weight-loss drugs in the UK on the drug.
Dubbed the “King Kong” of weight-loss medication, Mounjaro, the brand name for tirzepatide, has helped almost a third of people lose a quarter of their bodyweight, according to a trial presented at the European Congress on Obesity this year.
